Technology Evaluation

ITA thoughtfully evaluates technology disclosures and devises tailored commercialization and IP protection plans.

 

There are several factors we consider when we evaluate your innovation and you, as the inventor and expert in your scientific area, remain critical in aiding this process. Some of the questions we evaluate include:

+ Commercialization Potential

  • What is the product and its commercial need?
  • Will a company need exclusivity to commercialize this innovation?

+ IP Protection Necessary to Protect the Technology

  • Is it a therapeutic, diagnostic or device?
  • Is it a software product, app or copyright? 
  • Is it a research tool, such as a transgenic model, cell line or non-therapeutic antibody? 

As a general rule, products requiring significant financial input before they reach the market will benefit from patent protection. Examples include therapeutics, diagnostics and devices. Software and apps are already protected under copyright law. Research tools have inherent property rights and therefore rarely require patent protection for successful commercialization.

+ Stage of Development

  • How far along is the product?
  • Is funding available to move the product to the next stage of development?
  • What work is needed to further validate the technology?

+ Some factors considered by companies when deciding whether to take a license to a UCSF technology

  • Stage of development and strength of data
  • Market size
  • Market demand/unmet need
  • Whether the product is novel, a me-too product, or an improvement to an existing product
  • Strength of patent rights and ability to exclude competitors from the market
  • Legal issues, such as ownership of the product, need to license additional rights from a third party, etc.
  • If the inventor is interested in starting a company to develop the technology.

IP Protection and Commercialization Plan

Working closely with the inventor(s), ITA’s evaluation process results in the generation of an IP protection and commercialization plan, with an eventual goal of licensing the technology to an external partner.